AveXis, Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AveXis, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AveXis, Inc. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
| Mar 30 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
| Mar 30 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
| Mar 30 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
| Mar 30 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
| Mar 30 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
| Mar 30 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
| Mar 30 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Grant | A | 0.00 | 1,106 | 0 | 228,752 | 227.6 K to 228.8 K (+0.49 %) |
| Mar 30 2018 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
| Mar 30 2018 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
| Mar 30 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
| Mar 30 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
| Mar 27 2018 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Option Exercise | A | 133.80 | 9,233 | 1,235,375 | 9,233 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Grant | A | 0.00 | 2,308 | 0 | 2,308 | 0 to 2.3 K |
| Mar 27 2018 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Option Exercise | A | 133.80 | 6,572 | 879,334 | 6,572 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Grant | A | 0.00 | 1,667 | 0 | 1,667 | 0 to 1.7 K |
| Mar 27 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 3,800 | 0 | 3,800 | 0 to 3.8 K |
| Mar 27 2018 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Option Exercise | A | 133.80 | 10,000 | 1,338,000 | 10,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Mar 27 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Grant | A | 0.00 | 3,800 | 0 | 3,800 | 0 to 3.8 K |
| Mar 27 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Grant | A | 0.00 | 3,800 | 0 | 8,800 | 5 K to 8.8 K (+76.00 %) |
| Mar 27 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Grant | A | 0.00 | 3,800 | 0 | 1,770,602 | 1.8 M to 1.8 M (+0.22 %) |
| Mar 27 2018 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Option Exercise | A | 133.80 | 10,000 | 1,338,000 | 10,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Mar 27 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Grant | A | 0.00 | 3,800 | 0 | 3,800 | 0 to 3.8 K |
| Mar 27 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | A | 133.80 | 44,000 | 5,887,200 | 44,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | M | 15.94 | 10,000 | 159,400 | 728,300 | |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 131.86 | 1,100 | 145,046 | 0 | 1.1 K to 0 (-100.00 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 130.78 | 600 | 78,468 | 1,100 | 1.7 K to 1.1 K (-35.29 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 129.66 | 4,800 | 622,368 | 1,700 | 6.5 K to 1.7 K (-73.85 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 128.65 | 2,400 | 308,760 | 6,500 | 8.9 K to 6.5 K (-26.97 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 127.65 | 700 | 89,355 | 8,900 | 9.6 K to 8.9 K (-7.29 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 126.65 | 400 | 50,660 | 9,600 | 10 K to 9.6 K (-4.00 %) |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Buy | M | 15.94 | 10,000 | 159,400 | 10,000 | 0 to 10 K |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 178,494 | |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 128.91 | 50 | 6,446 | 0 | 50 to 0 (-100.00 %) |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 127.99 | 408 | 52,220 | 50 | 458 to 50 (-89.08 %) |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 126.95 | 504 | 63,983 | 458 | 962 to 458 (-52.39 %) |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 125.72 | 449 | 56,448 | 962 | 1.4 K to 962 (-31.82 %) |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 124.29 | 175 | 21,751 | 1,411 | 1.6 K to 1.4 K (-11.03 %) |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 123.16 | 120 | 14,779 | 1,586 | 1.7 K to 1.6 K (-7.03 %) |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 121.51 | 74 | 8,992 | 1,706 | 1.8 K to 1.7 K (-4.16 %) |
| Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |